P-592 Neoadjuvant chemo- and radiotherapy in stage IIIA (N2) non-small cell lung cancer (NSCLC). Rationale for a radomized trial by the swiss group for clinical cancer research (SAKK)
Pless, Miklos, Stahel, Rolf, Balmer-Majno, Sabine, Stupp, Roger, Betticher, Daniel, Egli, Franz, Rufibach, Kaspar, Thierstein, Sandra, Ris, Hans-Beat, Mirimanoff, Rene-OlivierVolume:
41
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(03)92559-1
Date:
August, 2003
File:
PDF, 196 KB
english, 2003